Patients taking medication for lifestyle-related comorbid diseases, such as hypertension, dyslipidemia, and diabetes, were included
Some medications are approved for people with obesity, while some are also approved for people classified as having overweight but not obesity
These numbers reflect reference reconstitution math as reported in research contexts and are shared strictly for research-use-only purposes, not medical advice
Non-GLP-1 weight loss medications offer alternatives for patients unable to tolerate GLP-1-related gastrointestinal effects
Part D enrollment is still required, and the Bridge is processed separately through the central processor
Proteomic analysis of mesenchymal stem-like cells derived from ovarian teratoma: potential role of glutathione S-transferase M2 in ovarian teratoma